Keywords: biovitrum, manufacturing, deal, resistentia, biopharmaceutical, firm, listed

Biovitrum in manufacturing deal with Resistentia

Article | 13 November 2006

Biopharmaceutical firm Biovitrum, listed on the Stockholm, Sweden, Stock Exchange since September 15, has entered an agreement with the Uppsala-based biotechnology ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing